Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Gilbert

Showing results (141-150 of 869) with videos related to

Pageof 87
Sort By:
Journal of Analytical Toxicology|March 1, 1995
A labetalol metabolite with analytical characteristics resembling amphetaminesR B Gilbert, P I Peng, D Wong
Biometrics|March 2, 2005
Two-sample tests for comparing intra-individual genetic sequence diversity between populationsPeter B Gilbert, A J Rossini, Raj Shankarappa
Journal of Biopharmaceutical Statistics|August 9, 2006
Joint inferences on vaccine efficacy against infection and disease with application to the first HIV vaccine efficacy trialT Cai, P B Gilbert, S G Self
Current HIV Research|February 3, 2007
Identification of cross-neutralization determinants by GAP analysis: a mutational behavior approachFusheng Li, Peter B Gilbert, Steve G Self
Journal of the American Chemical Society|November 20, 2019
Catalytic, Enantioselective <i>syn-</i>Diamination of AlkenesZhonglin Tao, Bradley B Gilbert, Scott E Denmark
Current Opinion in HIV and AIDS|May 31, 2013
Sieve analysis in HIV-1 vaccine efficacy trialsPaul T Edlefsen, Peter B Gilbert, Morgane Rolland
Biostatistics (Oxford, England)|August 21, 2007
The 2-sample problem for failure rates depending on a continuous mark: an application to vaccine efficacyPeter B Gilbert, Ian W McKeague, Yanqing Sun
Statistics in Medicine|April 3, 2016
Power/sample size calculations for assessing correlates of risk in clinical efficacy trialsPeter B Gilbert, Holly E Janes, Yunda Huang
Current Opinion in HIV and AIDS|September 24, 2016
Modeling HIV vaccine trials of the futurePeter B Gilbert, Ying Huang, Holly E Janes
Statistics in Medicine|January 14, 2009
Response to Andrew Dunning's comment on 'evaluating a surrogate endpoint at three levels, with application to vaccine development'Peter B Gilbert, Li Qin, Steven G Self
Pageof 87

Showing results (141-150 of 869) with videos related to

Sort By:
Pageof 87
Journal of Analytical Toxicology|March 1, 1995
A labetalol metabolite with analytical characteristics resembling amphetaminesR B Gilbert, P I Peng, D Wong
Biometrics|March 2, 2005
Two-sample tests for comparing intra-individual genetic sequence diversity between populationsPeter B Gilbert, A J Rossini, Raj Shankarappa
Journal of Biopharmaceutical Statistics|August 9, 2006
Joint inferences on vaccine efficacy against infection and disease with application to the first HIV vaccine efficacy trialT Cai, P B Gilbert, S G Self
Current HIV Research|February 3, 2007
Identification of cross-neutralization determinants by GAP analysis: a mutational behavior approachFusheng Li, Peter B Gilbert, Steve G Self
Journal of the American Chemical Society|November 20, 2019
Catalytic, Enantioselective <i>syn-</i>Diamination of AlkenesZhonglin Tao, Bradley B Gilbert, Scott E Denmark
Current Opinion in HIV and AIDS|May 31, 2013
Sieve analysis in HIV-1 vaccine efficacy trialsPaul T Edlefsen, Peter B Gilbert, Morgane Rolland
Biostatistics (Oxford, England)|August 21, 2007
The 2-sample problem for failure rates depending on a continuous mark: an application to vaccine efficacyPeter B Gilbert, Ian W McKeague, Yanqing Sun
Statistics in Medicine|April 3, 2016
Power/sample size calculations for assessing correlates of risk in clinical efficacy trialsPeter B Gilbert, Holly E Janes, Yunda Huang
Current Opinion in HIV and AIDS|September 24, 2016
Modeling HIV vaccine trials of the futurePeter B Gilbert, Ying Huang, Holly E Janes
Statistics in Medicine|January 14, 2009
Response to Andrew Dunning's comment on 'evaluating a surrogate endpoint at three levels, with application to vaccine development'Peter B Gilbert, Li Qin, Steven G Self
Pageof 87